Roche prepares launch of breast cancer pill giredestrant amid patient anticipation
read at Endpoints ↗Positive
Roche is gearing up for the launch of its new oral breast cancer therapy, giredestrant.
Teresa Graham, head of Roche's pharma unit, said patients are anxiously awaiting the drug.
The announcement highlights Roche's focus on expanding treatment options for breast cancer, though no details on regulatory approval or pricing were provided.
source
This writeup was produced by pharmadog from original reporting by Endpoints.
Original headline: “Roche says it will help patients who are 'anxiously awaiting' its new breast cancer drug”
read at Endpoints ↗87 words · retrieved 59m ago
comments(0)
5-min edit window · permanent after that